Detailed contribution information
| Contribution title | Effects of Mogamulizumab on CD39, CD73 and CD38 ectonucleotidases expression in patients with Sézary syndrome |
|---|---|
| Authors | |
| Form of presentation | Poster |
| Topic |
|
| Contribution title | Effects of Mogamulizumab on CD39, CD73 and CD38 ectonucleotidases expression in patients with Sézary syndrome |
|---|---|
| Authors | |
| Form of presentation | Poster |
| Topic |
|